Where an applicant for a marketing authorisation for a veterinary medicinal product or for a variation to the terms of a marketing authorisation submits an application in accordance with Regulation (EC) No 470/2009 for the establishment of a maximum residue limit, together with safety and residues tests and pre-clinical studies and clinical trials during the application procedure, other applicants shall not refer to results of those tests, studies and trials for a period of five years from the granting of the marketing authorisation for which they were carried out.
I gcás ina dtíolacann iarratasóir ar údarú margaíochta do tháirge íocshláinte tréidliachta nó ar mhodhnú ar théarmaí de chuid údarú margaíochta iarratas i gcomhréir le Rialachán (CE) Uimh. 470/2009 chun uasleibhéal iarmhar a bhunú, mar aon le tástálacha ar iarmhair, staidéir réamhchliniciúla agus trialacha cliniciúla le linn an nós imeachta iarratais, ní dhéanfaidh iarratasóirí eile tagairt do thorthaí na dtástálacha, na staidéar agus na dtrialacha sin ar feadh tréimhse 5 bliana ón uair ar deonaíodh an t-údarú margaíochta a ndearnadh iad ina leith.